BLPL has an Dedicated Formulation R & D centre where  formulations using New Drug Delivery systems are developed

BLPL has been granted 6 patents by IPO for NDDS for 5 Hydro alcoholic gels for Hormone replacement therapy

Further We have developed Non Infringing Novel Lyophilised formulation for Docetaxel  Anhydrous & are in Discussions for Licensing the same to interested companies

We prepare Dossiers as per CTD format for EU & US guidelines & offer the same to interested clients for applying for Market authorizations.